Status:
RECRUITING
Biomarkers in Transplant Recipients to Improve Outcomes
Lead Sponsor:
University of Pittsburgh
Conditions:
Solid Organ Transplantation
Bone Marrow Transplantation
Eligibility:
All Genders
Brief Summary
The objective of this study is to evaluate whether certain proteins, expressed in biological tissues can indict a better understanding of the effect of drugs that are used to treat rejection, and of p...
Detailed Description
All transplant recipients receive periodic monitoring of drug levels and laboratory tests to assess adequacy of immunosuppression and allograft function. These are performed when the recipient is admi...
Eligibility Criteria
Inclusion
- Recipients of abdominal, thoracic and bone marrow allografts that are receiving inpatient and outpatient follow-up with routine laboratory tests at the University of Pittsburgh Medical Center.
- All Ages
- Subject or parents are able to read and understand the informed consent
Exclusion
- Subjects and/or their parents who are unable to read and understand informed consent.
Key Trial Info
Start Date :
March 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2030
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT01163578
Start Date
March 1 2005
End Date
March 1 2030
Last Update
September 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Pittsburgh of UPMC
Pittsburgh, Pennsylvania, United States, 15224